ArticleCancer science2025

ONO-4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.

Akihito Kawazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.